Herbert J Conrad's Net Worth
$5.73 Million
Who is Herbert J Conrad?
Herbert J Conrad has an estimated net worth of $5.73 Million. This is based on reported shares across multiple companies, which include SAVIENT PHARMACEUTICALS INC, TEKMIRA PHARMACEUTICALS CORP, Celldex Therapeutics, Inc., Matinas BioPharma Holdings, Inc., Pharmasset Inc, and BONE CARE INTERNATIONAL INC.
SEC CIK
Herbert J Conrad's CIK is 0001218815
Past Insider Trading and Trends
2007 was Herbert J Conrad's most active year for acquiring shares with 15 total transactions. Herbert J Conrad's most active month to acquire stocks was the month of May. 2007 was Herbert J Conrad's most active year for disposing of shares, totalling 22 transactions. Herbert J Conrad's most active month to dispose stocks was the month of September. 2004 saw Herbert J Conrad paying a total of $551,093.93 for 44,673 shares, this is the most they've acquired in one year. In 2005 Herbert J Conrad cashed out on 103,424 shares for a total of $2,286,768.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
SAVIENT PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +14.06% | 3.51K |
$11.38 | $39,989.32 | 28.5K |
Jun 8
| |||
Form 4
| +42.47% | 7.45K |
$5.37 | $39,995.76 | 24.99K |
May 5
| |||
Form 4
| +10.19% | 1.62K |
$24.66 | $39,998.52 | 17.54K |
May 13
| |||
Form 4
|
—
|
0
|
$13.22 | -$214,125.00 | 15.92K |
May 2 - May 6
| |||
Form 4
| -38.58% | -10.00K |
$9.05 | -$221,770.50 | 15.92K |
Apr 1 - Apr 2
| |||
Form 4
|
—
|
0
|
$13.86 | -$180,600.00 | 25.92K |
Mar 3 - Mar 4
| |||
Form 4
|
—
|
0
|
$11.67 | -$159,665.00 | 25.92K |
Feb 1 - Feb 4
| |||
Form 4
|
—
|
0
|
$13.50 | -$208,395.00 | 25.92K |
Jan 2 - Jan 3
| |||
Form 4
|
—
|
0
|
$13.33 | -$16,275.00 | 25.92K |
Nov 28 - Nov 30
| |||
Form 4
|
—
|
0
|
$13.46 | -$16,485.00 | 25.92K |
Oct 10
| |||
Form 4
|
—
|
0
|
$11.48 | -$97,065.00 | 25.92K |
Oct 5 - Oct 9
| |||
Form 4
|
—
|
0
|
$11.70 | -$19,112.50 | 25.92K |
Oct 3
| |||
Form 4
| +14.47% | 3.28K |
$12.77 | $41,847.29 | 25.92K |
May 15
| |||
Form 4
| +1.39% | 311 |
$12.02 | $3,738.22 | 22.64K |
Mar 30
| |||
Form 4/A
| +1.52% | 334 |
$11.21 | $3,744.14 | 22.33K |
Dec 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 29
| |||
Form 4
| +2.69% | 576 |
$6.51 | $3,749.76 | 22K |
Sep 29
| |||
Form 4/A
| +3.45% | 714 |
$5.25 | $3,748.50 | 21.42K |
Jun 30
| |||
Form 4
| +3.45% | 714 |
$5.25 | $3,748.50 | 21.42K |
Jun 30
| |||
Form 4
| +3.51% | 703 |
$5.33 | $3,746.99 | 20.7K |
Mar 31
| |||
Form 4
| +5.27% | 1K |
$3.74 | $3,747.48 | 20K |
Dec 30
| |||
Form 4
| +5.52% | 994 |
$3.77 | $3,747.38 | 19K |
Sep 30
| |||
Form 4
| +4.95% | 850 |
$4.41 | $3,748.50 | 18.01K |
Jun 30
| |||
Form 4
| +8.84% | 1.39K |
$2.69 | $3,749.86 | 17.16K |
Mar 31
| |||
Form 4
| +9.62% | 1.38K |
$2.71 | $3,747.93 | 15.76K |
Dec 31
| |||
Form 4
| +12.79% | 1.63K |
$2.30 | $3,749.00 | 14.38K |
Sep 30
| |||
Form 4
| +8.59% | 1.01K |
$2.48 | $2,499.84 | 12.75K |
Jun 30
| |||
Form 4
| +5.88% | 652 |
$3.83 | $2,497.16 | 11.74K |
Mar 31
| |||
Form 4
| +5.14% | 542 |
$4.61 | $2,498.62 | 11.09K |
Dec 31
| |||
Form 4/A
| +4.92% | 495 |
$5.05 | $2,499.75 | 10.55K |
Sep 30
| |||
Form 4
| +4.92% | 495 |
$4.14 | $2,049.30 | 10.55K |
Sep 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Arbutus Biopharma Corp (ABUS) Snapshot price: $4.5488
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Celldex Therapeutics, Inc. (CLDX) Snapshot price: $44
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
| +35.09% | 10K |
—
|
—
| 38.5K |
Jun 15
| |||
Form 4
| +54.05% | 10K |
—
|
—
| 28.5K |
Jun 8
| |||
Form 4
| +54.17% | 6.5K |
—
|
—
| 18.5K |
Jun 10
| |||
Form 4
| +20.00% | 2K |
—
|
—
| 12K |
Jun 4
| |||
Form 4
| +25.00% | 2K |
—
|
—
| 10K |
Jun 19
| |||
Form 4
| +33.33% | 2K |
—
|
—
| 8K |
Jun 20
| |||
Form 4
|
∞
| 2K |
—
|
—
| 2K |
Jun 22
| |||
Form 4
|
∞
| 2K |
—
|
—
| 2K |
Sep 22
| |||
Form 4
|
∞
| 2K |
—
|
—
| 2K |
Dec 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Matinas BioPharma Holdings, Inc. (MTNB) Snapshot price: $3.45
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 14
| |||
Form 4
|
—
|
0
|
—
|
—
| 4.69M |
Aug 4 - Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 1
| |||
Form 4
|
—
|
0
|
—
|
—
| 4.2M |
Jul 7
| |||
Form 4
| +18.17% | 240K |
—
|
—
| 1.56M |
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
| 1.82M |
Jan 13 - May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 2
| |||
Form 4
| +5.83% | 30K |
—
|
—
| 544.62K |
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
| 2.76M |
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
| 3.91M |
May 13
| |||
Form 4
| +2.10% | 10.57K |
—
|
—
| 514.62K |
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 1
| |||
Form 4
| +154.59% | 306.07K |
—
|
—
| 504.05K |
Jul 29 - Sep 30
| |||
Form 4
| +16.48% | 28K |
—
|
—
| 197.98K |
Jun 30
| |||
Form 4
| +16.90% | 25K |
$0.96 | $24,115.00 | 172.96K |
May 16
| |||
Form 4
| +22.02% | 22.02K |
—
|
—
| 122.02K |
Mar 31
| |||
Form 4
| -97.52% | -3.93M |
—
|
—
| 100K |
Feb 8
| |||
Form 4
| +1.01% | 40.34K |
—
|
—
| 4.03M |
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 1
| |||
Form 4
| +0.66% | 26.09K |
—
|
—
| 3.99M |
Oct 1
| |||
Form 4
| +1.41% | 55.3K |
—
|
—
| 3.97M |
Jun 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
| +0.81% | 31.58K |
—
|
—
| 3.91M |
Mar 30
| |||
Form 4
| +2.65% | 100K |
$1.30 | $130,000.00 | 3.88M |
Sep 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Pharmasset Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
|
∞
| 2K |
—
|
—
| 2K |
Sep 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||